Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation and Management of Dyspnea in Hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorder (HSD)

NCT04972565 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04972565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04972565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation and Management of Dyspnea in Hypermobile Ehlers-Danlos Syndrome (hEDS) and Hypermobility Spectrum Disorder (HSD)
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
August 16, 2021
Completion date
March 21, 2025
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypermobile eds (heds), hypermobility syndrome